Article
A PCR-RFLP based protocol for the detection of hepatitis B virus variants in some lamivudine-untreated chronic hepatitis B virus carriers in Pakistan.
Pakistan journal of pharmaceutical sciences - 1 Apr 2012
Tauseef Isfahan, Iqbal Furhan, Rehman Wajid, Ali Muhammad, Qureshi Javed Anver, Aslam Muhammad Assad
Abstract excerpt
Hepatitis B virus (HBV) affects more than 350 million people worldwide and is a leading cause of morbidity and mortality in developing countries like Pakistan. Lamivudine has potential to inhibit hepatitis B virus (HBV) replication but long term lamivudine treatment results in mutations in YMDD region of HBV, making this therapy ineffective. In this study, we have optimized a polymerase chain reaction-restriction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
